Journal article
X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity.
-
Lerner C
Laboratorium für Organische Chemie, ETH-Zentrum Universitätstrasse 16, 8092 Zürich (Switzerland) Fax: (+41) 1-632-1109.
-
Ruf A
Pharma Division, Präklinische Forschung F. Hoffmann-La Roche AG, 4002 Basel (Switzerland).
-
Gramlich V
Laboratorium für Kristallographie, ETH-Zentrum Sonneggstrasse 5, 8092, Zürich (Switzerland).
-
Masjost B
Laboratorium für Organische Chemie, ETH-Zentrum Universitätstrasse 16, 8092 Zürich (Switzerland) Fax: (+41) 1-632-1109.
-
Zürcher G
Pharma Division, Präklinische Forschung F. Hoffmann-La Roche AG, 4002 Basel (Switzerland).
-
Jakob-Roetne R
Pharma Division, Präklinische Forschung F. Hoffmann-La Roche AG, 4002 Basel (Switzerland).
-
Borroni E
Pharma Division, Präklinische Forschung F. Hoffmann-La Roche AG, 4002 Basel (Switzerland).
-
Diederich F
Laboratorium für Organische Chemie, ETH-Zentrum Universitätstrasse 16, 8092 Zürich (Switzerland) Fax: (+41) 1-632-1109.
Show more…
Published in:
- Angewandte Chemie (International ed. in English). - 2001
English
With an IC50 value of 9 nM, 1 is the most potent known disubstrate inhibitor for catechol-O-methyltransferase (COMT). Inhibition of COMT is of significant interest in the therapy of Parkinsonapos;s disease since it ensures that a larger percentage of orally administered L-dopa reaches-in the form of dopamine-its target in the brain. The X-ray crystal structure of a complex formed by COMT and 1 has been solved at 2.6-Å resolution.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/37310
Statistics
Document views: 25
File downloads: